TMEM88 and hepatocellular carcinoma: Although the downstream signaling pathway of TMEM88 in HCC was not explored here, it is high likely that TMEM88 functions through inhibiting Wnt/β-catenin signaling pathways as reported in various cancer types (16, 17, 19).